Showing 1 - 10 of 16
Persistent link: https://www.econbiz.de/10010344943
This paper examines the evolution of the pharmaceutical industry. After a brief discussion of the main stylised facts about the industry, we present a history-friendly model that aims at capturing the underlining mechanisms and the logic that guides the evolution of this industry. Simulation...
Persistent link: https://www.econbiz.de/10010704427
concentration through a partially endogenous process of discovery of new submarkets. However, it is not simply market fragmentation …
Persistent link: https://www.econbiz.de/10011001837
fragmentation as such that produces this result, but rather the entity of the “prize” that innovators can gain relative to the …
Persistent link: https://www.econbiz.de/10008788562
In this paper we present a model of the long term dynamics of market structure and innovation in the pharmaceutical industry in a history friendly way. Our results show a strong increase in concentration in each therapeutic area, but a rather low level of concentration in the overall market....
Persistent link: https://www.econbiz.de/10005169682
Persistent link: https://www.econbiz.de/10001277914
The contribution of this paper is twofold. First, it presents the results of a “history-friendly” simulation model of evolution of the pharmaceutical industry. Second, it aims at contributing to a more general methodological discussion about agent-based models by proposing an econometric...
Persistent link: https://www.econbiz.de/10010907946
Persistent link: https://www.econbiz.de/10001798471
Persistent link: https://www.econbiz.de/10001799761
Persistent link: https://www.econbiz.de/10009618913